- Previous Close
986.95 - Open
1,014.40 - Bid --
- Ask 954.05 x --
- Day's Range
950.05 - 1,021.40 - 52 Week Range
451.50 - 1,083.80 - Volume
519,992 - Avg. Volume
201,666 - Market Cap (intraday)
24.781B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
24.27 - EPS (TTM)
39.31 - Earnings Date Feb 11, 2025 - Feb 15, 2025
- Forward Dividend & Yield 3.00 (0.39%)
- Ex-Dividend Date Jul 26, 2024
- 1y Target Est
--
Cosmo First Limited engages in the manufacture and sale of bi-axially oriented polypropylene (BOPP) films in India and internationally. The company offers packaging films; lamination films; label films; and industrial films to food, beverage, personal care, and pharmaceutical industries. It also offers specialty chemicals; and operates retail and services platform that provides a range of pet care products, such as food, nutritional supplements, hygiene products, accessories, and toys, as well as vet care, grooming, and training services. In addition, the company provides pathology, radiology, pharmacy, surgeries, vaccination, and consultation services for vet care practices. Further, it offers pet spa and pet products. The company was formerly known as Cosmo Films Limited and changed its name to Cosmo First Limited in July 2022. Cosmo First Limited was incorporated in 1976 and is based in New Delhi, India.
www.cosmofirst.com1,241
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: COSMOFIRST.NS
View MorePerformance Overview: COSMOFIRST.NS
Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COSMOFIRST.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COSMOFIRST.NS
View MoreValuation Measures
Market Cap
24.76B
Enterprise Value
32.13B
Trailing P/E
24.29
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.94
Price/Book (mrq)
1.74
Enterprise Value/Revenue
1.21
Enterprise Value/EBITDA
10.40
Financial Highlights
Profitability and Income Statement
Profit Margin
3.03%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
26.19B
Net Income Avi to Common (ttm)
792.4M
Diluted EPS (ttm)
39.31
Balance Sheet and Cash Flow
Total Cash (mrq)
4.07B
Total Debt/Equity (mrq)
77.78%
Levered Free Cash Flow (ttm)
--